Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Martorell, PM; de las Heras, BB; Perez-Fidalgo, JA; Alvaro, MH; Martin, M; Albanell, J; Hernandez, AL.

Subcutaneous trastuzumab: drug development and current position

Clinical & Translational Oncology. 2014; 16(10): 859-864 Nº de citas: 2 [doi:10.1007/s12094-014-1181-y]

Castello, A; Pollan, M; Buijsse, B; Ruiz, A; Casas, AM; Baena-Canada, JM; Lope, V; Antolin, S; Ramos, M; Munoz, M; Lluch, A; de Juan-Ferre, A; Jara, C; Jimeno, MA; Rosado, P; Diaz, E; Guillem, V; Carrasco, E; Perez-Gomez, B; Vioque, J; Boeing, H; Martin, M.

Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case-control EpiGEICAM study

BRITISH JOURNAL OF CANCER. 2014; 111(7): 1454-1462 Nº de citas: 157 [doi:10.1038/bjc.2014.434]

Calvo, FA; Sole, CV; Rivera, S; Meirino, R; Lizarraga, S; Infante, MA; Boldo, E; Ferrer, C; Marsiglia, H; Deutsch, E.

The use of radiotherapy for early breast cancer in woman at different ages

Clinical & Translational Oncology. 2014; 16(8): 680-685 Nº de citas: 9 [doi:10.1007/s12094-014-1164-z]

de Andres, C; Tejera-Alhambra, M; Alonso, B; Valor, L; Teijeiro, R; Ramos-Medina, R; Mateos, D; Faure, F; Sanchez-Ramon, S.

New regulatory CD19(+)CD25(+) B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoids

JOURNAL OF NEUROIMMUNOLOGY. 2014; 270(1-2): 37-44 Nº de citas: 54 [doi:10.1016/j.jneuroim.2014.02.003]

Ramos-Medina, R; Garcia-Segovia, A; Gil, J; Carbone, J; de la Cruz, AA; Seyfferth, A; Alonso, B; Alonso, J; Leon, JA; Alecsandru, D; Melia, E; de Albornoz, EC; Ordonez, D; Santillan, I; Verdu, V; de Morales, JMGR; Lopez-Hoyos, M; Larios, AL; Sampalo, A; Caballero, P; Quintana, LO; Fernandez-Cruz, E; Sanchez-Ramon, S.

Experience in IVIg Therapy for Selected Women with Recurrent Reproductive Failure and NK Cell Expansion

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2014; 71(5): 458-466 Nº de citas: 59 [doi:10.1111/aji.12217]

Wheeler, HE; Gonzalez-Neira, A; Pita, G; de la Torre-Montero, JC; Alonso, R; Lopez-Fernandez, LA; Alba, E; Martin, M; Dolan, ME.

Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analyses

PHARMACOGENETICS AND GENOMICS. 2014; 24(5): 231-237 Nº de citas: 14 [doi:10.1097/FPC.0000000000000037]

Rosmarin, D; Palles, C; Church, D; Domingo, E; Jones, A; Johnstone, E; Wang, HT; Love, S; Julier, P; Scudder, C; Nicholson, G; Gonzalez-Neira, A; Martin, M; Sargent, D; Green, E; McLeod, H; Zanger, UM; Schwab, M; Braun, M; Seymour, M; Thompson, L; Lacas, B; Boige, V; Ribelles, N; Afzal, S; Enghusen, H; Jensen, SA; Etienne-Grimaldi, MC; Milano, G; Wadelius, M; Glimelius, B; Garmo, H; Gusella, M; Lecomte, T; Laurent-Puig, P; Martinez-Balibrea, E; Sharma, R; Garcia-Foncillas, J; Kleibl, Z; Morel, A; Pignon, JP; Midgley, R; Kerr, D; Tomlinson, I.

Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis

JOURNAL OF CLINICAL ONCOLOGY. 2014; 32(10): 1031-1039 Nº de citas: 207 [doi:10.1200/JCO.2013.51.1857]

Romero, A; Prat, A; Garcia-Saenz, JA; del Prado, N; Pelayo, A; Furio, V; Roman, JM; de la Hoya, M; Diaz-Rubio, E; Perou, CM; Clades, T; Martin, M.

Assignment of tumor subtype by genomic testing and pathologic-based approximations: implications on patient's management and therapy selection

Clinical & Translational Oncology. 2014; 16(4): 386-394 Nº de citas: 21 [doi:10.1007/s12094-013-1088-z]

Tejera-Alhambra, M; Casrouge, A; de Andres, C; Ramos-Medina, R; Alonso, B; Vega, J; Albert, ML; Sanchez-Ramon, S.

Low DPP4 expression and activity in multiple sclerosis

CLINICAL IMMUNOLOGY. 2014; 150(2): 170-183 Nº de citas: 36 [doi:10.1016/j.clim.2013.11.011]

Marquez-Rodas, I; Lopez-Tarruella, S; Jerez, Y; Cavanagh, M; Custodio, S; Lopez-Trabada, D; Moya, B; Perez, S; Ruperez, AB; Martin, M.

Evaluation of a Heredofamilial Cancer Unit in Increasing Family History Collection and Genetic Counseling Referrals Among Spanish Oncologists at a University Hospital

Journal of Genetic Counseling. 2014; 23(1): 108-113 Nº de citas: 4 [doi:10.1007/s10897-013-9617-z]

Sole, CV; Calvo, FA; Lozano, MA; Gonzalez-Bayon, L; Gonzalez-Sansegundo, C; Alvarez, A; Lizarraga, S; Garcia-Sabrido, JL.

External-beam radiation therapy after surgical resection and intraoperative electron-beam radiation therapy for oligorecurrent gynecological cancer

STRAHLENTHERAPIE UND ONKOLOGIE. 2014; 190(2): 171-180 Nº de citas: 16 [doi:10.1007/s00066-013-0472-5]

Aebi, S; Gelber, S; Anderson, SJ; Lang, I; Robidoux, A; Martin, M; Nortier, JWR; Paterson, AHG; Rimawi, MF; Canada, JMB; Thurlimann, B; Murray, E; Mamounas, EP; Geyer, CE; Price, KN; Coates, AS; Gelber, RD; Rastogi, P; Wolmark, N; Wapnir, IL.

Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial

LANCET ONCOLOGY. 2014; 15(2): 156-163 Nº de citas: 169 [doi:10.1016/S1470-2045(13)70589-8]

de Maturana, EL; Chanok, SJ; Picornell, AC; Rothman, N; Herranz, J; Calle, ML; Garcia-Closas, M; Marenne, G; Brand, A; Tardon, A; Carrato, A; Silverman, DT; Kogevinas, M; Gianola, D; Real, FX; Malats, N.

Whole Genome Prediction of Bladder Cancer Risk With the Bayesian LASSO

GENETIC EPIDEMIOLOGY. 2014; 38(5): 467-476 Nº de citas: 8 [doi:10.1002/gepi.21809]

Martin, M; Brase, JC; Calvo, L; Krappmann, K; Ruiz-Borrego, M; Fisch, K; Ruiz, A; Weber, KE; Munarriz, B; Petry, C; Rodriguez, CA; Kronenwett, R; Crespo, C; Alba, E; Carrasco, E; Casas, M; Caballero, R; Rodriguez-Lescure, A.

Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2-breast cancer patients: results from the GEICAM 9906 trial

BREAST CANCER RESEARCH. 2014; 16(2): Nº de citas: 125 [doi:10.1186/bcr3642]

Di Leo, A; Jerusalem, G; Petruzelka, L; Torres, R; Bondarenko, IN; Khasanov, R; Verhoeven, D; Pedrini, JL; Smirnova, I; Lichinitser, MR; Pendergrass, K; Malorni, L; Garnett, S; Rukazenkov, Y; Martin, M.

Final Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM Trial

JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2014; 106(1): Nº de citas: 208 [doi:10.1093/jnci/djt337]

Rodriguez, PR; Serrano, FP; Caicedo, LPM; de Guzman, MCR; Presmanes, MC; Diez, JD.

Pulmonary Veno-Occlusive Disease in a Female Gardener

ARCHIVOS DE BRONCONEUMOLOGIA. 2014; 50(1): 40-41 Nº de citas: 1 [doi:10.1016/j.arbres.2013.05.010]

Martin, M; Bonneterre, J; Geyer, CE; Ito, Y; Ro, J; Lang, I; Kim, SB; Germa, C; Vermette, J; Wang, K; Wang, KM; Awada, A.

A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+advanced breast cancer

EUROPEAN JOURNAL OF CANCER. 2013; 49(18): 3763-3772 Nº de citas: 134 [doi:10.1016/j.ejca.2013.07.142]

Gomez, JG; Lopez, MEP; Bermejo, MA; Alvarez, YE; Mata, JG.

SEOM guide to antiemetic prophylaxis in cancer patients treated with chemotherapy 2013

Clinical & Translational Oncology. 2013; 15(12): 1030-1036 Nº de citas: 2 [doi:10.1007/s12094-013-1093-2]